Feb 29 |
Amicus Therapeutics: Expect Improved Commercial Momentum In 2024
|
Feb 29 |
Q4 2023 Amicus Therapeutics Inc Earnings Call
|
Feb 28 |
Amicus Therapeutics, Inc. (FOLD) Q4 2023 Earnings Call Transcript
|
Feb 28 |
Amicus Therapeutics, Inc. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 28 |
Amicus Therapeutics (FOLD) Reports Q4 Loss, Lags Revenue Estimates
|
Feb 28 |
Amicus Therapeutics Inc (FOLD) Reports 21% Revenue Growth in 2023, Eyes Non-GAAP Profitability ...
|
Feb 28 |
Amicus Therapeutics Non-GAAP EPS of $0.01 beats by $0.05, revenue of $115.08M in-line
|
Feb 28 |
Amicus Therapeutics Announces Full-Year 2023 Financial Results and Corporate Updates
|
Feb 27 |
Amicus Therapeutics Q4 2023 Earnings Preview
|
Feb 15 |
Amicus Therapeutics to Announce Full Year 2023 Financial Results on February 28, 2024
|